Monthly Communication Report

Corporation:	Amgen Canada Inc.
Associated registration:	952471-15332-36
Communication date:	2025-10-01
Posted date:	2025-10-27

Designated Public Office Holders who participated in the communication:	Justine Frame, Special Assistant, Policy Office of the Minister, Health Canada (HC) Sandenga Yeba, Director of Policy & Deputy Chief of Staff Office of the Minister, Health Canada (HC)
List of Details Subject matter Detail Health, Science and Technology Communicating with government officials about the implementation, renewal and expansion of the "National Strategy for Drugs for Rare Diseases" (2023).
Responsible Officer who filed this communication report:	Ugur Gunaydin
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.